$245.25 USD (0.00% 24h)
As of 2026-09-18 06:20 UTC. Source: The Crypto App market data. USD snapshot, not a live tick.
Alnylam Pharmaceuticals, Inc. is a leading global biopharmaceutical company at the forefront of developing innovative RNA interference (RNAi) therapeutics. The company pioneered the translation of Nobel Prize-winning science into an entirely new class of innovative medicines. Utilizing its proprietary drug delivery technology platforms, Alnylam is dedicated to the R&D, manufacturing, and commercialization of…